09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3555<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
Maria Clementine Martin Klosterfrau<br />
Vertriebsgesellschaft mbH, DE<br />
EP 1886690<br />
Maria Clementine Martin Klosterfrau<br />
Vertriebsgesellschaft mbH, DE<br />
A61K 36/185 (2006.01)<br />
A61K 31/352 (2006.01)<br />
A61K 38/47 (2006.01)<br />
A61K 31/4415 (2006.01)<br />
A61P 1/00 (2006.01)<br />
A61K 9/00 (2006.01)<br />
A61K 9/10 (2006.01)<br />
A61K 9/20 (2006.01)<br />
A61K 31/00 (2006.01)<br />
A61K 33/00 (2006.01)<br />
A61K 36/23 (2006.01)<br />
Markon Holdings Limited, NZ E03C 1/04 (2006.01)<br />
A47K 3/16 (2006.01)<br />
MARX, Thomas A., US A61B 17/132 (2006.01)<br />
Massachusetts Institute of Technology, C12N 15/10 (2006.01)<br />
US<br />
C12P 7/06 (2006.01)<br />
Mazence Inc., KR A61K 31/33 (2006.01)<br />
A61K 31/453 (2006.01)<br />
A61K 9/32 (2006.01)<br />
A61P 3/10 (2006.01)<br />
A61P 3/04 (2006.01)<br />
Mazence Inc., KR A61K 31/343 (2006.01)<br />
A61K 31/453 (2006.01)<br />
A61K 9/32 (2006.01)<br />
A61P 3/10 (2006.01)<br />
A61P 3/04 (2006.01)<br />
Mazence Inc., KR A61K 31/34 (2006.01)<br />
A61P 9/00 (2006.01)<br />
Mazence Inc., KR A61K 31/352 (2006.01)<br />
Mccool, James, US A61K 9/20 (2006.01)<br />
A61K 31/325 (2006.01)<br />
A61K 47/02 (2006.01)<br />
MeadWestvaco Corporation, US B65D 83/04 (2006.01)<br />
Merck & Co., Inc., US C07D 498/08 (2006.01)<br />
C07D 498/18 (2006.01)<br />
C07K 5/08 (2006.01)<br />
C07K 5/10 (2006.01)<br />
C07K 5/12 (2006.01)<br />
A61K 31/40 (2006.01)<br />
A61K 38/06 (2006.01)<br />
A61K 38/07 (2006.01)<br />
A61K 31/12 (2006.01)<br />
Merck & Co., Inc., US C07D 401/14 (2006.01)<br />
C07D 413/14 (2006.01)<br />
C07D 471/04 (2006.01)<br />
C07D 487/04 (2006.01)<br />
C07D 491/048 (2006.01)<br />
C07D 491/052 (2006.01)<br />
C07D 495/04 (2006.01)<br />
A61K 31/551 (2006.01)<br />
A61P 3/04 (2006.01)<br />
A61P 25/20 (2006.01)<br />
C07D 403/14 (2006.01)<br />
Merck & Co., Inc., US C07D 231/56 (2006.01)<br />
C07D 401/10 (2006.01)<br />
C07D 403/10 (2006.01)<br />
A61K 31/416 (2006.01)<br />
A61P 5/44 (2006.01)<br />
Merck & Co., Inc., US C07D 231/56 (2006.01)<br />
C07D 401/10 (2006.01)<br />
C07D 403/10 (2006.01)<br />
A61K 31/416 (2006.01)<br />
A61P 5/44 (2006.01)<br />
Merck Frosst Canada Ltd., CA C07D 413/14 (2006.01)<br />
A61K 31/454 (2006.01)<br />
A61P 3/00 (2006.01)<br />
C07D 417/14 (2006.01)<br />
Merial Limited, US A61K 39/08 (2006.01)<br />
Merial Limited, US A61M 5/00 (2006.01)<br />
Merial Ltd., US A61K 38/18 (2006.01)<br />
A61K 48/00 (2006.01)<br />
A61P 13/12 (2006.01)<br />
Merial Ltd., US A61K 39/02 (2006.01)<br />
A61P 31/04 (2006.01)<br />
Millennium Pharmaceuticals, Inc., US C07D 487/04 (2006.01)<br />
A61K 31/55 (2006.01)<br />
A61P 35/00 (2006.01)<br />
EP 2088999 *<br />
EP 2089580 *<br />
EP 2<strong>09</strong>9366 *<br />
EP 2<strong>09</strong>9910 *<br />
EP 2<strong>09</strong>4261 *<br />
EP 2<strong>09</strong>4262 *<br />
EP 2<strong>09</strong>9448 *<br />
EP 2<strong>09</strong>9449 *<br />
EP 2089002 *<br />
EP 2<strong>09</strong>1842 *<br />
EP 2086982 *<br />
EP 2089382 *<br />
EP 2<strong>09</strong>1922 *<br />
EP 2<strong>09</strong>7385 *<br />
EP 2<strong>09</strong>9793 *<br />
EP 2086580 *<br />
EP 2<strong>09</strong>4332 *<br />
EP 2<strong>09</strong>9472 *<br />
EP 2<strong>09</strong>9479 *<br />
EP 2086981 *<br />
Pharmaceutical composition for the treatment of food<br />
intolerance<br />
PHARMACEUTICAL COMPOSITION COMPRISING AN<br />
ACTIVE INGREDIENT WHICH NEUTRALIZES AND/OR<br />
BINDS GASTRIC ACID, SUCH AS AN ALGINIC ACID<br />
DERIVATIVE<br />
MOUNTING APPARATUS FOR BATH FITTING<br />
TOURNIQUET SYSTEM<br />
GLOBAL TRANSCRIPTION MACHINERY<br />
ENGINEERING<br />
PHARMACEUTICAL COMPOSITION CONTAINING<br />
NAPHTHOQUINONE-BASED COMPOUND FOR<br />
INTESTINE DELIVERY SYSTEM<br />
PHARMACEUTICAL COMPOSITION CONTAINING<br />
PHENANTHRENEQUINONE-BASED COMPOUND<br />
FOR INTESTINE DELIVERY SYSTEM<br />
PHARMACEUTICAL COMPOSITION FOR<br />
TREATMENT AND PREVENTION OF RESTENOSIS<br />
PHARMACEUTICAL COMPOSITION FOR THE<br />
TREATMENT AND PREVENTION OF DISEASES<br />
INVOLVING IMPOTENCE<br />
PHENYLALKYL CARBAMATE COMPOSITIONS<br />
BLISTER PACK SECONDARY PACKAGE<br />
HCV NS3 PROTEASE INHIBITORS<br />
SUBSTITUTED DIAZEPAN COMPOUNDS AS OREXIN<br />
RECEPTOR ANTAGONISTS<br />
2-[1-PHENYL-5-HYDROXY-4ALPHA-METHYL-<br />
HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL<br />
PHENYL DERIVATIVES AS GLUCOCORTICOID<br />
RECEPTOR LIGANDS<br />
2-[1-PHENYL-5-HYDROXY OR METHOXY-4ALPHA-<br />
METHYL-HEXAHYDROCLOPENTA[F]INDAZOL-5-<br />
YL]ETHYL PHENYL DERIVATIVES AS<br />
GLUCOCORTICOID RECEPTOR LIGANDS<br />
AZACYCLOALKANE DERIVATIVES AS INHIBITORS<br />
OF STEAROYL-COENZYME A DELTA-9<br />
DESATURASE<br />
PRIME BOOST CANINE LEISHMANIA VACCINE<br />
MULTIPLE FLUID DELIVERY DEVICE FOR POULTRY<br />
INTRA-VASCULAR KIDNEY GENE THERAPY WITH<br />
PLASMID ENCODING BMP-7<br />
SALMONELLA VACCINE IN POULTRY<br />
COMPOUNDS FOR INHIBITING MITOTIC<br />
PROGRESSION<br />
ISSN 1331-2030